Micropace has responded to growing demands for its product following recent events involving Fisher imaging and its Bloom Electrophysiology Programmable Stimulator. Micropace has further increased production, currently 40% higher compared to previous year period. Micropace has also completed testing on Software Ver 3.21, which now supports the specialised functions provided by this hardware stimulator, allowing seamless transition to the Micropace software platform by even the most demanding users. The new features include:
- facility for near-simultaneous 4 channel pacing,
- implementation of multiple drive trains in addition to existing ATP protocol and
- AV sequential S1 drive train pacing mode for extra-stimuli.
A cross-platform instruction booklet will facilitate cross-training.